From hospital spending to cancer prevention, initial public offerings to fish oil pills, The Motley Fool's health-care team sits down each week to discuss the most fascinating developments in health care, and their implications for long-term investors. In this week's edition, the team talks about new trends in the health-care industry, a clinical trial that examined the efficacy of omega3 fatty acids, four everyday items that may contain chemicals linked to cancer, and two stocks that investors need to watch.

Editor's Note: Audio quality is poor in certain places. The Fool regrets this problem.